| Aug 10 |
Piper lists eight defensive biotechs to face market volatility
|
| Aug 7 |
Here's How Much You Would Have Made Owning Alnylam Pharmaceuticals Stock In The Last 10 Years
|
| Aug 7 |
The 3 Best Gene Editing Stocks to Buy in August 2024
|
| Aug 7 |
Alnylam to Present Detailed Results from the HELIOS-B Phase 3 Study of Vutrisiranā¼ in Patients with ATTR Amyloidosis with Cardiomyopathy at the European Society of Cardiology Congress 2024
|
| Aug 4 |
DoorDash And Exact Sciences Are Among Top 10 Large Cap Gainers Last Week (July 28-Aug 3): Are The Others In Your Portfolio?
|
| Aug 2 |
Alnylam (ALNY) Up as Q2 Earnings Beat on Collaboration Revenues
|
| Aug 2 |
Vir retreats from infectious disease; Vertex shelves AATD drugs
|
| Aug 1 |
Alnylam Pharmaceuticals, Inc. (ALNY) Q2 2024 Earnings Call Transcript
|
| Aug 1 |
Air Products Posts Upbeat Earnings, Joins Meta, Exact Sciences, Shake Shack, Clearwater Analytics And Other Big Stocks Moving Higher On Thursday
|
| Aug 1 |
Alnylam (ALNY) Reports Q2 Earnings: What Key Metrics Have to Say
|
